⌕
Inspire Medical Systems · INSP · NYSE
Tenet 68 · Solid
Compare
$59.41+0.49%At closeTenet 68 · Solid
$59.41+0.29 (+0.49%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Inspire Medical Systems (INSP) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineGrowing fast: revenue compounds ~40.6%/yr (FY21→FY25), net margin 15.9%; free cash flow runs at 54% of net income. Check the accrual gap. Worth your attention in FY25: Share count (+9.1%) and Returns vs FCF (223%). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲13.6%
912.0
FY21→FY25CAGR +40.6%/yr
Net income ($M)▲171.8%
145.4
one-off year: see footnoteCAGR —
Free cash flow ($M)▼13.9%
78.5
FY21→FY25CAGR —
Diluted EPS▲179.4%
4.89
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+9.1%

27.3mn → 29.8mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex
$38.5M

steady at 4.2% of revenue (−1.6% YoY).

Returns vs FCF
223%

$175.0M returned vs $78.5M of FCF in FY25. The gap comes off the balance sheet (see net cash).

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)912.0Revenue−133.2COGS778.8Gross profit−103.2R&D−624.6SG&A51.0Op income94.5Tax & other145.4Net income

16¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
906845230%sector median net margin ~3%FY21FY25

Over this window: gross 85.7% → 85.4%. Net margin 15.9% is more than double the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
880,936.0911,981.0802,804.0624,799.0407,856.0233,394.0▲13.6%+40.6%
Cost of revenue
121,701.0133,225.0122,986.096,576.066,115.033,279.0▲8.3%+41.5%
Gross profit
759,235.0778,756.0679,818.0528,223.0341,741.0200,115.0▲14.6%+40.5%
Research & development
97,642.0103,165.0114,128.0116,536.068,645.037,350.0▼9.6%+28.9%
Selling, general & admin
645,830.0624,637.0529,607.0451,958.0320,688.0202,615.0▲17.9%+32.5%
Total operating expenses
743,472.0727,802.0643,735.0568,494.0389,333.0239,965.0▲13.1%+32.0%
Operating incomefeeds ROC rank
15,763.050,954.036,083.0−40,271.0−47,592.0−39,850.0▲41.2%—
Other income, net
15,058.014,743.022,370.020,365.03,324.0−2,120.0——
Pretax income
30,821.065,697.058,453.0−19,906.0−44,268.0−41,970.0▲12.4%—
Income tax
−69,895.0−79,725.04,944.01,247.0613.072.0——
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
100,716.0145,422.053,509.0−21,153.0−44,881.0−42,042.0▲171.8%—
Per share
Diluted EPSbuyback-sensitive
3.354.891.75−0.72−1.60−1.54▲179.4%—
Diluted shares (mn)
28.9329.7630.5429.3028.0727.26▼2.6%+2.2%
Margins
Gross margin80th pct in Healthcare
86.2%85.4%84.7%84.5%83.8%85.7%▲0.7pp−0.3pp
Operating margin
1.8%5.6%4.5%−6.4%−11.7%−17.1%▲1.1pp+22.7pp
Net margin71st pct in Healthcare
11.4%15.9%6.7%−3.4%−11.0%−18.0%▲9.3pp+34.0pp
† TTM = trailing four quarters through 2026-09-30.FY24 effective tax rate was 8% vs a −1% norm for this window, likely a one-time item; see the filing.FY25 effective tax rate was −121% vs a −1% norm for this window, likely a one-time item; see the filing.
FY16 – FY20 · 5 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-13 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Inspire Medical Systems' revenue last fiscal year?

Inspire Medical Systems reported revenue of $912.0M in fiscal 2025, up 13.6% from fiscal 2024.

What was Inspire Medical Systems' net income?

Inspire Medical Systems reported net income of $145.4M in fiscal 2025, a net margin of 15.9%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.